Baker to leave GE PACS unit

Article

When GE Medical Systems bought PACS firm Lockheed Martin Medical Imaging Systems in April, it said its plan was to retain all 130 employees at the company, including chief executive Michael Baker (SCAN 4/30/97). Less than three months later, however, GE

When GE Medical Systems bought PACS firm Lockheed Martin Medical Imaging Systems in April, it said its plan was to retain all 130 employees at the company, including chief executive Michael Baker (SCAN 4/30/97). Less than three months later, however, GE has confirmed that Baker is leaving the division, which has been incorporated into GE's Integrated Imaging Solutions business. Baker reported to Anthony Lombardo, the head of Integrated Imaging Solutions.

Nor is Baker the only one who has left the unit. Also leaving are several other Lockheed Martin veterans, including some engineering talent. The departures are not a sign of a culture clash between GE and Lockheed Martin, however, according to GE spokesperson Charlie Young. Rather, the moves are typical of the employee turnover that occurs after a change in corporate ownership.

"In any acquisition, you can expect a certain amount of churn in the organization," Young said. "Some people are energized by that, and others feel that they need to explore other options to stay on whatever career path they have set."

Young said GE has probably not moved as quickly as it might like in integrating the former Lockheed Martin unit with its own operations, due to the location of the division's headquarters, which is in the same building as the nuclear medicine unit of GE rival Siemens. GE has found a new location for the business, however, in Mount Prospect, IL, about 15 miles away from the Hoffman Estates building. The business should begin moving to the Mount Prospect facility in mid-August or early September.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.